Recent advances in neoadjuvant immunotherapy for urothelial bladder cancer: What to expect in the near future-Reference-Cited by-同舟云学术

Recent advances in neoadjuvant immunotherapy for urothelial bladder cancer: What to expect in the near future

Published:2021-02 Issue: Volume:93 Page:102142
ISSN:0305-7372
Container-title:Cancer Treatment Reviews
language:en
Short-container-title:Cancer Treatment Reviews

Author:

Rey-Cárdenas M.^ORCID,Guerrero-Ramos F.,Gómez de Liaño Lista A.,Carretero-González A.,Bote H.,Herrera-Juárez M.,Carril-Ajuria L.,Martín-Soberón M.,Sepulveda J.M.,Billalabeitia E.G.,Castellano D.,de Velasco G.

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging,Oncology,General Medicine

Reference62 articles.

1. Enhancement of antitumor immunity by CTLA-4 blockade;Leach;Science,1996

2. Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death;Ishida;EMBO J,1992

3. Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade;Iwai;Proc Natl Acad Sci USA,2002

4. The evolving landscape of ‘next-generation’ immune checkpoint inhibitors: A review;Mazzarella;Eur J Cancer,2019

5. The second wave of immune checkpoint inhibitor tsunami: advance, challenges and perspectives;Kourie;Immunotherapy,2017

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. BHLHE41 inhibits bladder cancer progression via regulation of PYCR1 stability and thus inactivating PI3K/AKT signaling pathway;European Journal of Medical Research;2024-05-29

2. Chest wall tumor following intravesical BCG instillation for non-muscle invasive bladder cancer;Journal of Clinical Tuberculosis and Other Mycobacterial Diseases;2024-05

3. Healthcare resource utilization and associated costs in patients with metastatic urothelial carcinoma: a real-world analysis using German claims data;Journal of Medical Economics;2024-04-19

4. The efficacy and safety of tislelizumab combined with gemcitabine plus cisplatin in the treatment of postoperative patients with muscle-invasive upper tract urothelial carcinoma;BMC Cancer;2024-02-13

5. FGL2 as a predictive biomarker for prognosis and immunotherapy in bladder cancer;International Journal of Medical Sciences;2024